<?xml version='1.0' encoding='us-ascii'?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">
<DOCID>29</DOCID>
<TEXT>
Exhibit . [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e0">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e1">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e2">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e3">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE b- <EVENT class="COREFERENCE" eid="e4">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED Manufacturing Agreement Between Antares Pharma, Inc. and AMAG Pharmaceuticals, Inc. [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e5">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e6">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e7">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e8">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE b- <EVENT class="COREFERENCE" eid="e9">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED MANUFACTURING AGREEMENT This Manufacturing Agreement ("Agreement") is <EVENT class="COREFERENCE" eid="e10">made</EVENT> and <EVENT class="COREFERENCE" eid="e11">entered</EVENT> into as of the th day of March , (the "Effective Date ") by and between Antares Pharma, Inc., a Delaware corporation, with offices located at Princeton South, Suite , Ewing, NJ ("Antares"), and AMAG Pharmaceuticals, Inc., a Delaware corporation, with a corporate address at Winter Street, Waltham, MA ("AMAG"). Antares and AMAG are sometimes <EVENT class="COREFERENCE" eid="e12">referred</EVENT> to herein individually as a "Party" and collectively as the "Parties". Recitals WHEREAS, AMAG is <EVENT class="COREFERENCE" eid="e13">engaged</EVENT> in discovering , developing and marketing pharmaceutical products, including the Drug (as <EVENT class="COREFERENCE" eid="e14">defined</EVENT> below); WHEREAS, Antares is <EVENT class="COREFERENCE" eid="e15">engaged</EVENT> in the <EVENT class="COREFERENCE" eid="e16">research</EVENT> and <EVENT class="COREFERENCE" eid="e17">development</EVENT> of certain drug delivery devices, including auto-injection systems and the <EVENT class="COREFERENCE" eid="e18">development</EVENT> and <EVENT class="COREFERENCE" eid="e19">marketing</EVENT> of pharmaceutical products; WHEREAS, AMAG Pharma USA, Inc. (f/k/a Lumara Health, Inc., ("AMAG USA")), which was <EVENT class="COREFERENCE" eid="e20">acquired</EVENT> by AMAG on November , and is a wholly- owned subsidiary of AMAG, and Antares <EVENT class="COREFERENCE" eid="e21">entered</EVENT> into a certain Development and License Agreement ( <EVENT class="COREFERENCE" eid="e22">defined</EVENT> below) under which Antares <EVENT class="COREFERENCE" eid="e23">granted</EVENT> AMAG USA an exclusive, worldwide license to Antares' VIBEXÂ® QuickShotÂ® (QS) auto-injection system or similar Device ( <EVENT class="COREFERENCE" eid="e24">defined</EVENT> below) for use with the Drug, and further under which Antares and AMAG USA <EVENT class="COREFERENCE" eid="e25">agreed</EVENT> to <EVENT class="COREFERENCE" eid="e26">collaborate</EVENT> to <EVENT class="COREFERENCE" eid="e27">develop</EVENT> such a product; WHEREAS, contemporaneously with the <EVENT class="COREFERENCE" eid="e28">execution</EVENT> of this Agreement, Antares, AMAG and AMAG USA are entering into a First Amendment to Development and License Agreement, pursuant to which, among other amendments set forth therein, AMAG USA <EVENT class="COREFERENCE" eid="e29">assigned</EVENT> , and AMAG <EVENT class="COREFERENCE" eid="e30">assumed</EVENT> , the rights and responsibilities under the Development and License Agreement (the "First Amendment to Development and License Agreement"); WHEREAS, AMAG (as the <EVENT class="COREFERENCE" eid="e31">permitted</EVENT> assignee of the Development and License Agreement) and Antares <EVENT class="COREFERENCE" eid="e32">agreed</EVENT> under the Development and License Agreement to <EVENT class="COREFERENCE" eid="e33">enter</EVENT> into this Agreement and, whereby it will <EVENT class="COREFERENCE" eid="e34">provide</EVENT> Antares or its Subcontractor ( defined below) with Prefilled Syringes ( defined below) containing the Drug and Antares or it Subcontractor will <EVENT class="COREFERENCE" eid="e35">incorporate</EVENT> the Prefilled Syringes into Devices to <EVENT class="COREFERENCE" eid="e36">produce</EVENT> <EVENT class="COREFERENCE" eid="e37">finished</EVENT> Products ( defined below) and sample Products to <EVENT class="COREFERENCE" eid="e38">supply</EVENT> AMAG's requirements for such Products and sample Products; and WHEREAS, AMAG <EVENT class="COREFERENCE" eid="e39">wishes</EVENT> to <EVENT class="COREFERENCE" eid="e40">purchase</EVENT> , and Antares <EVENT class="COREFERENCE" eid="e41">wishes</EVENT> to <EVENT class="COREFERENCE" eid="e42">supply</EVENT> , AMAG's requirements of the Trainers ( defined below) on the terms set forth in this Agreement. NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and promises <EVENT class="COREFERENCE" eid="e43">contained</EVENT> in this Agreement, the Parties hereto <EVENT class="COREFERENCE" eid="e44">agree</EVENT> as follows : - - [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e45">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e46">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e47">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e48">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO <EVENT class="COREFERENCE" eid="e49">RULE</EVENT> b- <EVENT class="COREFERENCE" eid="e50">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED ARTICLE INTERPRETATION . Definitions. Capitalized terms <EVENT class="COREFERENCE" eid="e51">used</EVENT> in this Agreement and not otherwise <EVENT class="COREFERENCE" eid="e52">defined</EVENT> in this Section . shall have the meanings set out in the Development and License Agreement. The following terms shall, unless the context otherwise <EVENT class="COREFERENCE" eid="e53">requires</EVENT> , have the respective meanings set out below and grammatical variations of such terms shall have corresponding meanings: "[***]" has the meaning specified in Section . (c); "[***]" has the meaning specified in Section . (c); [***] "Agreement" has the meaning specified in the Preamble; "AMAG" has the meaning specified in the Preamble; "AMAG Indemnitees" has the meaning specified in Section . ; "AMAG USA" has the meaning specified in the Recitals; "AMAG Quality Tasks" means AMAG's quality, testing and release obligations set forth in Section . (b) and in the Quality Agreement; "Annual Product Review Report" means the annual product review report as described in Title of the United States Code of Federal Regulations, Section . (e); "Annual Report" means the annual report as described in Title of the United States Code of Federal Regulations, Section . (b)( ); "Antares" has the meaning specified in the Preamble; "Antares' Fully <EVENT class="COREFERENCE" eid="e54">Burdened</EVENT> Manufacturing Costs" means those costs actually incurred by Antares related directly to the <EVENT class="COREFERENCE" eid="e55">acquisition</EVENT> of materials and their <EVENT class="COREFERENCE" eid="e56">conversion</EVENT> into Products, sample Products or Trainers, as the case may be. [***]; "Antares Indemnitees" has the meaning specified in Section . ; "Batch Record" means a detailed, step-by-step description of the entire assembly, packaging and labelling process for the Products and sample Products which explains how such Products or sample Products (as the case may be) were assembled, packaged and labelled, indicating specific types and quantities of Components, additional materials, processing parameters, in- process quality controls, and other relevant controls; - - [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e57">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e58">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e59">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e60">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE b- <EVENT class="COREFERENCE" eid="e61">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED "Binding Forecast" has the meaning specified in Section . (a); "[***]" has the meaning specified in Section . (c); "Business Day" means a day other than a Saturday , Sunday or a day that is a federal holiday in the United States; "Calendar Quarter" means a three- ending on month period March , June , September or December ; "Calendar Year" means a calendar year occurring after the Effective Date ; provided, however, the first Calendar Year means the period from the Effective Date up to and including December of the same calendar year in which the Effective Date occurs; "[***]" has the meaning specified in Section . (c); "Certificate of Analysis (Device)" means a document signed by an authorized representative of Antares or the Subcontractor that conducted the applicable analysis, in reasonable and customary form, that: (i) describes the specifications for, and testing methods applied to, the quantity of each of the Major Device Components manufactured by or on behalf of Antares pursuant to this Agreement, and the results of such <EVENT class="COREFERENCE" eid="e62">testing</EVENT> and (ii) certifies that such quantity of each of the Major Device Components was manufactured in accordance with cGMP, all other Applicable Laws, and the Product Specifications; "Certificate of Analysis (PFS Manufacture)" means a document signed by an authorized representative of AMAG, its agent or its permitted subcontractor that conducted the applicable <EVENT class="COREFERENCE" eid="e63">analysis</EVENT> in reasonable and customary form, that: (i) describes the specifications for, and testing methods applied to the Drug manufactured by or on behalf of AMAG pursuant to this Agreement, and the results of such <EVENT class="COREFERENCE" eid="e64">testing</EVENT> and (ii) certifies that such quantity of Drug was manufactured in accordance with cGMP, all other Applicable Laws, and the Product Specifications; "Certificate of Analysis (PFS ID Testing)" means a document signed by an authorized representative of AMAG, its agent or its permitted subcontractor that conducted the applicable <EVENT class="COREFERENCE" eid="e65">analysis</EVENT> in reasonable and customary form, that describes the specifications for, and testing methods applied to, the Drug manufactured by or on behalf of AMAG pursuant to this Agreement for identification of the Drug, and the results of such <EVENT class="COREFERENCE" eid="e66">testing</EVENT> "Certificate of Analysis (Product)" means a document signed by an authorized representative of AMAG, its agent or its permitted subcontractor that conducted the applicable <EVENT class="COREFERENCE" eid="e67">analysis</EVENT> in reasonable and customary form, that: (i) describes the specifications for, and testing methods applied to, the quantity of Product and/or sample Product manufactured by or on behalf of Antares pursuant to this Agreement, and the results of such <EVENT class="COREFERENCE" eid="e68">testing</EVENT> and (ii) certifies that such quantity of Product and/or sample Product was - - [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e69">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e70">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e71">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e72">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE b- <EVENT class="COREFERENCE" eid="e73">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED <EVENT class="COREFERENCE" eid="e74">manufactured</EVENT> in accordance with cGMP, all other Applicable Laws, and the Product Specifications; "Certificate of Conformance (Device)" means the document provided to AMAG by Antares or the Subcontractor that conducted the applicable <EVENT class="COREFERENCE" eid="e75">review</EVENT> as the case may be, that certifies each batch of each of the Major Device Components was manufactured in compliance with the cGMP, all other Applicable Laws, and the Product Specifications; "Certificate of Conformance (Product)" means the document provided to AMAG by Antares or the Subcontractor that conducted the applicable <EVENT class="COREFERENCE" eid="e76">review</EVENT> as the case may be, that certifies each batch of Product and/or sample Product was assembled, packaged and labelled in compliance with the cGMP, all other Applicable Laws, and the Product Specifications; "cGMP" means current good manufacturing practice and standards as provided for (and as amended from time to time) in the " Current Good Manufacturing Practice Regulations" of the U.S. Code of Federal Regulations Title ( CFRÂ§ ; CFRÂ§ / and CFRÂ§ ) and in European Community Council Directive / /EEC concerning medical devices, any U.S., European, or other applicable laws, regulations or respective guidance documents now or subsequently established by a governmental or regulatory authority, and any arrangements, additions, or clarifications; " Change Order" has the meaning specified in Section . (b); "Commercially Reasonable <EVENT class="COREFERENCE" eid="e77">Efforts</EVENT> means, with respect to each Party, such <EVENT class="COREFERENCE" eid="e78">efforts</EVENT> and <EVENT class="COREFERENCE" eid="e79">commitment</EVENT> of resources in accordance with [***] that such Party [***]. As <EVENT class="COREFERENCE" eid="e80">used</EVENT> in this definition of "Commercially Reasonable <EVENT class="COREFERENCE" eid="e81">Efforts</EVENT> , "reasonable" shall be <EVENT class="COREFERENCE" eid="e82">measured</EVENT> by [***]. References in this Agreement to "commercially reasonable" and similar formulations shall be deemed to <EVENT class="COREFERENCE" eid="e83">incorporate</EVENT> the standard set forth in this definition of "Commercially Reasonable Efforts"; "Components" means, collectively, [***]; "Damages" has the meaning specified in Section . ; "Deficiency Notice" has the meaning specified in Section . (a); "Delivery Date " means the delivery date of a Purchase Order of Products, sample Products or Trainers as agreed upon by the Parties pursuant to Section . (b)(i) or Antares' proposed date if AMAG does not respond within the [***] set forth in Section . (b)(i); "Development and License Agreement" means that certain Development and License Agreement entered into by and between the Parties dated as of September , , as amended by the First Amendment to the Development and License Agreement, and as further amended by the Parties from time to time; - - [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e84">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e85">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e86">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e87">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO <EVENT class="COREFERENCE" eid="e88">RULE</EVENT> b- <EVENT class="COREFERENCE" eid="e89">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED "Device" means the VIBEXÂ® QS auto-injection system device, consisting of the Major Device Components, designed and developed to incorporate a Prefilled Syringe for <EVENT class="COREFERENCE" eid="e90">delivery</EVENT> of the Drug, and any <EVENT class="COREFERENCE" eid="e91">improvements</EVENT> or <EVENT class="COREFERENCE" eid="e92">modifications</EVENT> thereof made pursuant to the Development and License Agreement, or such other Antares-proprietary device as agreed to by Antares designed and developed to deliver the Drug pursuant to the Development and License Agreement, as further set forth on Exhibit B. For greater certainty, the Major Device Components are intended to be assembled with the Prefilled Syringe to produce a finished Product; "DHF" has the meaning specified in the Development and License Agreement; "DMF" has the meaning specified in the Development and License Agreement and is expanded to further clarify that a DMF is equivalent to an "MAF" or Master File; "Drug" means -alpha hydroxyprogesterone caproate; "Effective Date " has the meaning specified in the Preamble; [***] "Excess Order" has the meaning specified in Section . (b)(i); "Firm <EVENT class="COREFERENCE" eid="e93">Orders</EVENT> means any <EVENT class="COREFERENCE" eid="e94">Purchase</EVENT> Order accepted by Antares pursuant to Section . (b)(i) (as evidenced by an <EVENT class="COREFERENCE" eid="e95">Order</EVENT> Acceptance), including any Excess <EVENT class="COREFERENCE" eid="e96">Orders</EVENT> agreed to by Antares in an <EVENT class="COREFERENCE" eid="e97">Order</EVENT> Acceptance, with the Delivery Date as set forth in Section . (b)(i); "First Amendment to the Development and License Agreement" has the meaning specified in the Recitals; "Force Majeure <EVENT class="COREFERENCE" eid="e98">Event</EVENT> has the meaning specified in Section . ; "Forecast" has the meaning specified in Section . (a); "[***]" has the meaning specified in Section . ; "[***]" has the meaning specified in Section . (c); "[***]" has the meaning specified in Section . (c); "Invoice" has the meaning specified in Section . (a); "[***]" has the meaning specified in Section . (c); "Latent Defects" has the meaning specified in Section . (a); - - [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e99">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e100">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e101">REQUESTED</EVENT> . ALL SUCH OMITTED MATERIAL HAS BEEN <EVENT class="COREFERENCE" eid="e102">FILED</EVENT> WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE b- <EVENT class="COREFERENCE" eid="e103">PROMULGATED</EVENT> UNDER THE SECURITIES EXCHANGE ACT OF , AS AMENDED "Long Lead Time Materials" means [***], a description of which are set forth on Exhibit A (as such exhibit may be amended from time to time by the mutual written agreement of the Parties), [***]; "Major Device Components" means the following Components of the Device: [***]. "Manufacture(d) at Risk" has the meaning specified in Section . (a); "<EVENT class="COREFERENCE" eid="e104">Manufacturing</EVENT> Services" means the <EVENT class="COREFERENCE" eid="e105">manufacturing</EVENT> <EVENT class="COREFERENCE" eid="e106">quality</EVENT> control and <EVENT class="COREFERENCE" eid="e107">quality</EVENT> assurance, <EVENT class="COREFERENCE" eid="e108">storage</EVENT> <EVENT class="COREFERENCE" eid="e109">labelling</EVENT> <EVENT class="COREFERENCE" eid="e110">packaging</EVENT> <EVENT class="COREFERENCE" eid="e111">assembly</EVENT> and related <EVENT class="COREFERENCE" eid="e112">services</EVENT> to be performed by Antares or its Subcontractor as contemplated in this Agreement and described in the Specifications and the Quality Agreement, required to manufacture Devices and produce and supply Trainers, Products and sample Products from such Devices, Prefilled Syringes and Components. For the <EVENT class="COREFERENCE" eid="e113">avoidance</EVENT> of doubt, the "<EVENT class="COREFERENCE" eid="e114">Manufacturing</EVENT> Services" specifically <EVENT class="COREFERENCE" eid="e115">excludes</EVENT> the AMAG Quality <EVENT class="COREFERENCE" eid="e116">Tasks</EVENT> and all other <EVENT class="COREFERENCE" eid="e117">services</EVENT> <EVENT class="COREFERENCE" eid="e118">activities</EVENT> or <EVENT class="COREFERENCE" eid="e119">tasks</EVENT> to be <EVENT class="COREFERENCE" eid="e120">performed</EVENT> by or on behalf of AMAG set forth in this Agreement or as otherwise <EVENT class="COREFERENCE" eid="e121">described</EVENT> in the Specifications or the Quality Agreement; "Manufacturing Site" means [***] or such other facility owned and operated by Antares or a Subcontractor on behalf of Antares under this Agreement [***]. "Non-Binding Forecast" has the meaning specified in Section . (a); "Non-Cancellable Non-Returnable Materials" or "NCNR Materials" means [***]; [***] "<EVENT class="COREFERENCE" eid="e122">Order</EVENT> Acceptance" has the meaning specified in Section . (b)(i); "Other Approved Antares Product" has the meaning specified in Section . (a); "Parties" and "Party" have the meanings <EVENT class="COREFERENCE" eid="e123">specified</EVENT> in the Preamble; "Person" means any natural person, a corporation, a partnership, a trust, a joint venture, a limited liability company, any Governmental Authority or any other entity or organization; "[***]" has the meaning specified in Section . (b); "Prefilled Syringe" means the prefilled syringe containing the formulated Drug for incorporation into the Device, as further set forth in the Product Specifications; "Prior Orders" has the meaning specified in Section . (c); "Product(s)" means the fully packaged Device for auto-injection <EVENT class="COREFERENCE" eid="e124">delivery</EVENT> of the Drug incorporating a Prefilled Syringe and other applicable Components listed on Exhibit B - - [***] INDICATES MATERIAL THAT HAS BEEN <EVENT class="COREFERENCE" eid="e125">OMITTED</EVENT> AND FOR WHICH CONFIDENTIAL <EVENT class="COREFERENCE" eid="e126">TREATMENT</EVENT> HAS BEEN <EVENT class="COREFERENCE" eid="e127">REQUESTED</EVENT> .
</TEXT>
<MAKEINSTANCE aspect="NONE" eiid="ei7105" eventID="e0" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7106" eventID="e1" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7107" eventID="e2" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7108" eventID="e3" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7109" eventID="e4" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7110" eventID="e5" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7111" eventID="e6" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7112" eventID="e7" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7113" eventID="e8" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7114" eventID="e9" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7115" eventID="e10" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7116" eventID="e11" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7117" eventID="e12" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7118" eventID="e13" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7119" eventID="e14" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7120" eventID="e15" polarity="POS" pos="AUX" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7121" eventID="e16" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7122" eventID="e17" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7123" eventID="e18" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7124" eventID="e19" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7125" eventID="e20" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7126" eventID="e21" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7127" eventID="e22" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7128" eventID="e23" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7129" eventID="e24" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7130" eventID="e25" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7131" eventID="e26" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7132" eventID="e27" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7133" eventID="e28" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7134" eventID="e29" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7135" eventID="e30" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7136" eventID="e31" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7137" eventID="e32" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7138" eventID="e33" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7139" eventID="e34" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7140" eventID="e35" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7141" eventID="e36" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7142" eventID="e37" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7143" eventID="e38" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7144" eventID="e39" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7145" eventID="e40" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7146" eventID="e41" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7147" eventID="e42" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7148" eventID="e43" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7149" eventID="e44" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7150" eventID="e45" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7151" eventID="e46" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7152" eventID="e47" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7153" eventID="e48" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7154" eventID="e49" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7155" eventID="e50" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7156" eventID="e51" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7157" eventID="e52" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7158" eventID="e53" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7159" eventID="e54" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7160" eventID="e55" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7161" eventID="e56" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7162" eventID="e57" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7163" eventID="e58" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7164" eventID="e59" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7165" eventID="e60" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7166" eventID="e61" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7167" eventID="e62" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7168" eventID="e63" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7169" eventID="e64" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7170" eventID="e65" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7171" eventID="e66" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7172" eventID="e67" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7173" eventID="e68" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7174" eventID="e69" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7175" eventID="e70" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7176" eventID="e71" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7177" eventID="e72" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7178" eventID="e73" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7179" eventID="e74" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7180" eventID="e75" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7181" eventID="e76" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7182" eventID="e77" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7183" eventID="e78" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7184" eventID="e79" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7185" eventID="e80" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7186" eventID="e81" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7187" eventID="e82" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7188" eventID="e83" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7189" eventID="e84" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7190" eventID="e85" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7191" eventID="e86" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7192" eventID="e87" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7193" eventID="e88" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7194" eventID="e89" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7195" eventID="e90" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7196" eventID="e91" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7197" eventID="e92" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7198" eventID="e93" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7199" eventID="e94" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7200" eventID="e95" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7201" eventID="e96" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7202" eventID="e97" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7203" eventID="e98" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7204" eventID="e99" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7205" eventID="e100" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7206" eventID="e101" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7207" eventID="e102" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7208" eventID="e103" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7209" eventID="e104" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7210" eventID="e105" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7211" eventID="e106" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7212" eventID="e107" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7213" eventID="e108" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7214" eventID="e109" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7215" eventID="e110" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7216" eventID="e111" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7217" eventID="e112" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7218" eventID="e113" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7219" eventID="e114" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7220" eventID="e115" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7221" eventID="e116" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7222" eventID="e117" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7223" eventID="e118" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7224" eventID="e119" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7225" eventID="e120" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7226" eventID="e121" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7227" eventID="e122" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7228" eventID="e123" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7229" eventID="e124" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7230" eventID="e125" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7231" eventID="e126" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei7232" eventID="e127" polarity="POS" pos="VERB" tense="NONE" />
</TimeML>